Recruiting NCT05839678
How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cysts. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Netherlands
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Multicenter trial about anterior mediastinal cysts
Primary outcome measures
- Percentage correctly diagnosed cystic laesions [Time frame: 2000-2022]
Secondary outcome measures (1)
- Patient characteristics, complications, comborbidities [Time frame: 2000-2022]
Eligibility criteria
Inclusion Criteria: cysts in the anterior mediastinum
- Thymic cysts
- Bronchogenic cysts
- Pericardial cysts
- Cystic thymoma
- Cystic teratoma
Exclusion criteria
- Patients <18 years old
- Patients without radiological imaging
- Patients without approval for follow-up
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Other
Study locations
Netherlands · 1 center
- Maastricht UMC — Maastricht
Identifiers
NCT: NCT05839678 · 2022-3413